Chief Financial Officer

Senior Director of Technology, Gene Therapy

Biotechnology Instruments Market Projected to Reach US$ 141.70 Billion by 2035 | Astute Analytica

Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

Repligen executive chair Tony Hunt to retire, Martin Madaus to succeed

Repligen Corporation Announces Executive Changes, Effective March 13, 2026

Technical Applications Scientist, OPUS® Column

Repligen Corporation is a global leader in bioprocessing dedicated to improving human health. They are seeking a highly motivated Technical Applications Scientist to bridge customer experience and product performance, managing post-sales technical inquiries and collaborating cross-functionally to ensure the quality of the OPUS® pre-packed chromatography portfolio.

Repligen Corporation is a leader in bioprocessing, dedicated to improving human health through innovative biologic drug production. The Technical Applications Scientist will serve as a technical expert, managing post-sales inquiries, resolving product complaints, and collaborating cross-functionally to ensure high-quality performance of the OPUS® chromatography portfolio.

Technical Applications Scientist, Opus® Column in united states (1000+)

Technical Applications Scientist, OPUS® Column

Technical Applications Scientist, OPUS® Column